Last reviewed · How we verify
NCT04357184: BFRT
BFRT for Severe Lower Extremity Muscle Atrophy
NA trial testing Blood flow restriction training in Severe Muscle Atrophy in 100 participants. Completed in 15 February 2022.
15 February 2022
Quick facts
| Lead sponsor | Cincinnati Sportsmedicine Research and Education Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 14 April 2020 |
| Primary completion | 15 February 2022 |
| Estimated completion | 15 February 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood flow restriction training
Conditions studied
- Severe Muscle Atrophy — all drugs for Severe Muscle Atrophy →
- Muscle Weakness — all drugs for Muscle Weakness →
Sponsor
Cincinnati Sportsmedicine Research and Education Foundation
Who can join
Eligibility, any sex, with Severe Muscle Atrophy or Muscle Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle hypertrophy and strength gains. However, patients with severe muscle atrophy are frequently unable to tolerate these loads due to pain. Blood flow resistance training with low resistance loads may be used to safely develop muscle strength.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04357184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood flow restriction training
Trials testing the same drug.
- NCT07311031 — Effect of Blood Flow Restriction Rraining on Rehabilitation After Anterior Cruciate Ligament Reconstruction · NA · not yet recruiting
- NCT06906523 — Blood Flow Restriction in Older Adults · NA · active not recruiting
- NCT06441422 — Blood Flow Restriction Training for People With Disabilities · NA · recruiting
- NCT06709911 — A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis · NA · not yet recruiting
- NCT06398041 — Feasibility BFRT Geriatric Stroke Patients · NA · unknown
Other Cincinnati Sportsmedicine Research and Education Foundation trials
Trials by the same sponsor.
- NCT03039907 — Return to Physical Activities After Total Knee Arthroplasty · unknown
- NCT04746144 — Return Physical Activities After Total Knee Arthroplasty · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04357184 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cincinnati Sportsmedicine Research and Education Foundation
- Last refreshed: 16 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04357184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing